← Leaderboards
Jeanine M D'armiento
Columbia University Health Sciences
$14,757,679
Attributed
$19,890,887
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,890,887 · 13
By mechanism
R01$9,844,925 · 5
UH3$4,258,583 · 1
P01$2,410,985 · 3
UG3$1,673,582 · 1
RC1$968,763 · 1
R21$734,049 · 2
Top collaborators
- Lynne L. Johnson6 shared
- Charlton B Strange6 shared
- Gebhard Wagener3 shared
- Paul Timothy Elkington2 shared
- Suwan Jayasinghe2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Yonghao Yu$8,094,580
- Howard J Worman$18,931,900
- Yuxin Yin$3,921,764
- Patrick Lott Kinney$11,590,121
- James E Goldman$7,696,317
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungPathogenesisPulmonary EmphysemaLaboratoriesInjuryMeasurementGeneticGenerationsChronic Obstructive Airway DiseaseGenesAnimalsAnimal ModelResponseIn VivoMatrix MetalloproteinasesDisease ProgressionPhysiologicalPeptide HydrolasesSeveritiesPathway InteractionsTissuesLung DiseasesPreparationIn Vitro
Grant awards (43)
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease$808,451
UH3 · FY2025 · HL · contact PI
Molecular Biomarkers in pathogenesis of Lymphangioleiomyomatosis (LAM)$658,331
R01 · FY2025 · HL · contact PI
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease$1,112,779
UH3 · FY2024 · HL · contact PI
Molecular Biomarkers in pathogenesis of Lymphangioleiomyomatosis (LAM)$695,144
R01 · FY2024 · HL · contact PI
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease$1,159,459
UH3 · FY2023 · HL · contact PI
Molecular Biomarkers in pathogenesis of Lymphangioleiomyomatosis (LAM)$668,618
R01 · FY2023 · HL · contact PI
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease$1,177,894
UH3 · FY2022 · HL · contact PI
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease$933,377
UG3 · FY2021 · HL · contact PI
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease$740,205
UG3 · FY2020 · HL · contact PI
Role of Lung and Gut Microbiome in Lung Inflammation and Emphysema$202,500
R21 · FY2020 · ES · contact PI
Role of Lung and Gut Microbiome in Lung Inflammation and Emphysema$243,000
R21 · FY2019 · ES · contact PI
In vivo imaging of destructive processes in COPD$696,374
R01 · FY2018 · HL · contact PI
In vivo imaging of destructive processes in COPD$702,774
R01 · FY2017 · HL · contact PI
In vivo imaging of destructive processes in COPD$702,774
R01 · FY2016 · HL · contact PI
Smoke Induced Airway Injury in the Lung$548,264
R01 · FY2016 · HL · contact PI
Smoke Induced Airway Injury in the Lung$537,809
R01 · FY2015 · HL · contact PI
Smoke Induced Airway Injury in the Lung$526,325
R01 · FY2014 · HL · contact PI
Imaging RAGE Pro-inflammatory Signaling and Cellular Apoptosis in Emphysema$392,000
R01 · FY2014 · HL · contact PI
Smoke Induced Airway Injury in the Lung$541,512
R01 · FY2013 · HL · contact PI
Imaging RAGE Pro-inflammatory Signaling and Cellular Apoptosis in Emphysema$373,946
R01 · FY2013 · HL · contact PI
Targeting matrix metalloproteinases to limit immunopathology in airborne infectio$139,295
R21 · FY2013 · AI
Imaging RAGE Pro-inflammatory Signaling and Cellular Apoptosis in Emphysema$381,010
R01 · FY2012 · HL · contact PI
Targeting matrix metalloproteinases to limit immunopathology in airborne infectio$149,254
R21 · FY2012 · AI
Genetic Models and Phenotyping Core$319,180
P01 · FY2011 · HL · contact PI
CORE--Tissue Culture$110,772
P01 · FY2011 · HL · contact PI
Inducible Macrophage Specific Gene Expression in Diseases$492,404
RC1 · FY2010 · HL · contact PI
Smoke Induced Airway Injury in COPD$345,502
R01 · FY2010 · HL · contact PI
Genetic Models and Phenotyping Core$326,930
P01 · FY2010 · HL · contact PI
CORE--Tissue Culture$129,222
P01 · FY2010 · HL · contact PI
Inducible Macrophage Specific Gene Expression in Diseases$476,359
RC1 · FY2009 · HL · contact PI
Smoke Induced Airway Injury in COPD$382,595
R01 · FY2009 · HL · contact PI
CORE--Tissue Culture$219,688
P01 · FY2009 · HL · contact PI
Smoke Induced Airway Injury in COPD$394,172
R01 · FY2008 · HL · contact PI
CORE--Tissue Culture$215,295
P01 · FY2008 · HL · contact PI
Smoke Induced Airway Injury in COPD$402,650
R01 · FY2007 · HL · contact PI
CORE--Tissue Culture$219,858
P01 · FY2007 · HL · contact PI
Core B-Genetic Models and Phenotyping Core$157,362
P01 · FY2007 · HL · contact PI
Core--Genetic models and molecular signaling$369,215
P01 · FY2005 · HL
Core--Genetic models and molecular signaling$343,463
P01 · FY2002 · HL
ALTERED MATRIX METALLOPROTEINASES IN HEART FAILURE$298,375
R01 · FY2002 · AG
ALTERED MATRIX METALLOPROTEINASES IN HEART FAILURE$298,375
R01 · FY2001 · AG
Core--Genetic models and molecular signaling$0
P01 · FY2001 · HL
ALTERED MATRIX METALLOPROTEINASES IN HEART FAILURE$298,375
R01 · FY2000 · AG